Education
About Us
Working with TipRanks
Follow Us
Metsera, Inc. (MTSR)
:MTSR
MTSR Stock Chart & Stats
$70.50
--
Market closed
$70.50
--
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$448.46M
Total Debt (Recent Filing)$2.84M
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)9.69
Price to Sales (P/S)0.00
P/FCF Ratio-27.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
LeadershipThe company is led by highly experienced executives with strong track records.
Product EfficacyMonthly injectable GLP-1 data suggests equivalent efficacy to a competing weekly product, with potentially better tolerability.
Therapeutics PipelineThe company's platform and pipeline of novel obesity peptide-based therapeutics offer key advantages relative to competing assets.
Bears Say
Metsera, Inc. News
MTSR FAQ
What was Metsera, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Metsera, Inc.’s market cap?
Currently, no data Available
When is Metsera, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Metsera, Inc.’s earnings last quarter?
Metsera, Inc. released its earnings results on May 12, 2025. The company reported -$1.03 earnings per share for the quarter, missing the consensus estimate of -$0.945 by -$0.085.
Is Metsera, Inc. overvalued?
According to Wall Street analysts Metsera, Inc.’s price is currently Overvalued.
Does Metsera, Inc. pay dividends?
Metsera, Inc. does not currently pay dividends.
What is Metsera, Inc.’s EPS estimate?
Metsera, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Metsera, Inc. have?
Currently, no data Available
What happened to Metsera, Inc.’s price movement after its last earnings report?
Metsera, Inc. reported an EPS of -$1.03 in its last earnings report, missing expectations of -$0.945. Following the earnings report the stock price went down -5.732%.
Which hedge fund is a major shareholder of Metsera, Inc.?
Currently, no hedge funds are holding shares in MTSR
Technical Analysis
Cytokinetics
―
Soleno Therapeutics
―
ADMA Biologics
―
Crispr Therapeutics AG
―
Vaxcyte
―
Ownership Overview
3.88% Insiders
13.77% Mutual Funds
21.81% Other Institutional Investors
53.55% Public Companies and Individual Investors